title: Pulmonary thromboembolism with massive vaginal bleeding due to thrombolytic therapy.
abstract: Thrombolytic therapy may reduce the morbidity of pulmonary thromboembolism (PTE) and the risk of recurrent disease. The most important complication of thrombolytic therapy is bleeding. We report a patient with PTE complicated by massive vaginal bleeding due to thrombolytic therapy.
authors.affiliation: Gazi University School of Medicine, Department of Pulmonary Diseases, Ankara, Turkey. nekim@superonline.com
authors.forename: Numan
authors.initials: N
authors.lastname: Ekim
authors.forename: Nurdan
authors.initials: N
authors.lastname: Kokturk
authors.forename: Demet
authors.initials: D
authors.lastname: Yegin
authors.forename: Oguz
authors.initials: O
authors.lastname: Kokturk
authors.forename: M Ali
authors.initials: MA
authors.lastname: Habesoglu
mesh_terms: D000028:Abortion, Induced; D000328:Adult; D000075202:Contraindications; D005260:Female; D005343:Fibrinolytic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D011655:Pulmonary Embolism / Q000628:therapy*; D015912:Thrombolytic Therapy / Q000009:adverse effects; D010959:Tissue Plasminogen Activator / Q000009:adverse effects* / Q000627:therapeutic use; D014592:Uterine Hemorrhage / Q000139:chemically induced* / Q000628:therapy; D016306:Vena Cava Filters
chemical_list: D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator